Rocket Lab's Launch Pad, Not Its Balance Sheet, Now Sets the Tone for the Stock
Published on 10/19/2026 at 12:01 | Editorial boerse-global.de
Rocket Lab investors have spent the past week digesting a costly schedule slip on the company's big Neutron rocket. What comes next will be decided by something far smaller: the workhorse Electron launcher and a launch calendar that is about to get very busy.
The first test arrives on Wednesday, October 21, when Rocket Lab has scheduled the "We're Not Hawking Around" mission to carry three HawkEye 360 satellites to orbit. Two QPS missions are penciled in for November 4 and November 10 at the earliest, turning the coming weeks into a dense stretch of operational execution.
The shares were trading at 45.85 euros on Monday, up 1.3%, a modest rebound after Friday's 8.2% slide to 45.25 euros on the German market. That selloff followed the company's disclosure that Neutron's maiden flight has slipped to 2027.
A Tank Dome, Not a Strategy, Behind the Delay
The root cause is mechanical. Internal inspections found voids in the carbon-fiber composite layers of the forward dome on the first stage's fuel tank. Rocket Lab has said such a defect would not necessarily cause a failure in flight, but it falls short of the company's own safety standards. Management halted work, reworked the manufacturing process and is building a replacement section.
The decision pushed the first Neutron flight from a target of the fourth quarter of 2026 into 2027. Had the company pressed on to protect the original timeline, the entire heavy-lift program would have been exposed to far greater risk. A delay in development stings; a failure on the pad would be far worse.
Should investors sell immediately? Or is it worth buying Rocket Lab?
Targets Cut, Conviction Largely Intact
Analysts have trimmed their price targets without abandoning their constructive stances. Goldman Sachs lowered its target to $67 from $75 on October 15, keeping a Neutral rating and citing expected extra costs and a rising cash burn over the coming quarters. KeyBanc cut its target to $100 from $135 the same day but reaffirmed Overweight, pointing to the revised Neutron schedule as well as a broader de-rating and valuation discounts across high-growth space names.
Citizens moved on Friday, reducing its target to $90 from $130 while maintaining Outperform. Other houses trimmed their targets into a range of $90 to $122, mostly keeping positive recommendations in place. The message from Wall Street is consistent: valuation peaks are being shaved, but the underlying business case is not being thrown out.
Electron Carries the Load
With Neutron pushed out, the smaller Electron rocket becomes the financial backbone of the launch business. The question for the coming months is whether Rocket Lab can keep Electron's cadence and reliability high enough to bridge the longer development stretch without major disruption.
Every slip in the planned missions would add pressure. Investors are watching whether launch-site logistics and the Electron production chain mesh smoothly, with a clean run of upcoming flights seen as essential to rebuilding confidence after the recent weeks.
A flawless October 21 launch and prompt execution of the two November missions would demonstrate that the core business functions independently of the challenges facing the larger rocket. Sustained high launch rates would also show that demand for satellite transport remains firm and that customers are staying loyal.
Risks That Could Reignite the Selloff
Not everything points one way. The manufacturing changes carry the risk of further delays if the technical adjustments take longer than planned, widening the schedule gap. A regulatory filing added to the caution: on October 1, CFO Adam Spice sold 140,157 shares after exercising options over the same number of shares under a pre-arranged trading plan. Such transactions carry extra weight in an already jittery phase.
The stock also sits well below its 52-week high of 133.80 euros, a gap of 66% that reflects how much optimism has already been unwound. Setbacks on future missions could quickly revive the unease.
For now, the next concrete test is the October 21 launch attempt. A smooth flight and steady progress toward the November dates would offer a chance at a gradual floor. A broken Electron schedule, or fresh delays in the Neutron manufacturing steps, would leave the shares exposed to another leg lower.
Ad
Rocket Lab Stock: New Analysis - 19 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
